Skip to main content

Together we are beating cancer

Donate now

Prostate cancer

Around 47,700 men are diagnosed with prostate cancer in the UK each year, making it the most common cancer in men in the UK. It develops in the prostate, a walnut-sized gland found at the base of the bladder.
Showing 12 out of 239 results
  • Science & Technology

Tracking down the BRCA2 gene

Our scientists discovered the second breast cancer gene, BRCA2 - we discuss how they made the finding and what this means for cancer patients. Our scientists discovered the second breast cancer gene, BRCA2 - we discuss how they made the finding and what this means for cancer patients.

by Kat Arney | Analysis | 29 February 2012

29 February 2012

This entry is part 10 of 30 in the series Our milestones
%postcontent%
Cancer Research UK logo

Cancer Research UK welcomes the news that the All Wales Medicines Strategy Group (AWMSG) has made prostate cancer drug abiraterone available on the NHS, paving the way for NICE to make a positive ruling when they publish their final guidance in May. Cancer Research UK welcomes the news that the All Wales Medicines Strategy Group (AWMSG) has made prostate cancer drug abiraterone available on the NHS, paving the way for NICE to make a positive ruling when they publish their final guidance in May.

by Cancer Research UK | News | 20 February 2012

20 February 2012

Cancer Research UK logo

Cancer Research UK is urging a solution to the impasse over the advanced prostate cancer drug abiraterone, which has been turned down by NICE. Cancer Research UK is urging a solution to the impasse over the advanced prostate cancer drug abiraterone, which has been turned down by NICE.

by Cancer Research UK | News | 2 February 2012

2 February 2012